Publication | Closed Access
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
85
Citations
22
References
2022
Year
MedicineRefractory Colorectal CancerPathologyColorectal CancerMismatch Repair ProficientCancer TreatmentOncologyRadiation OncologyPhase I/ib Study
| Year | Citations | |
|---|---|---|
Page 1
Page 1